MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)
Application
US20260098092A1
Kind: A1
Apr 09, 2026
Inventors
Trairak Pisitkun, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao
Abstract
The present disclosure relates to antibodies and anti-gen-binding fragments that bind specifically to the human programmed cell death protein 1 (PD-1) and methods for treating cancer or other diseases with said antibodies and antigen-binding fragments.
CPC Classifications
C07K 16/2818
A61P 35/00
A61K 2039/505
C07K 2317/24
C07K 2317/52
C07K 2317/565
C07K 2317/76
C07K 2317/92
Filing Date
2023-10-04
Application No.
19114741